Posts Tagged ‘Novartis’
On Awe, Healthy Eating, Mental Health, Ethical Neurotech, and more
_____ Time to wrap-up another very active month with our SharpBrains e‑newsletter summarizing exciting developments in brain research, healthcare and technology — plus a couple fun brain teasers to spark curiosity and innovation :-) New brain research: Brain scans shed light on the brain networks supporting Awe For World Mental Health Day let’s review how a healthy…
Read MoreNovartis dissolves agreement to market Pear Therapeutics’ prescription digital therapeutics for substance/ opioid abuse
_______________ As Sandoz returns marketing rights for digital therapeutics to Pear, what does it mean for co-promote arrangements? (MM&M): “Sandoz, the generics division of Novartis, is altering commercial course, returning marketing duties for two prescription digital therapeutics (DTx) back to Pear Therapeutics. The move, which some had anticipated, comes 18 months after the two signed…
Read MoreCVS Health: Cognitive behavioral therapy (CBT) apps may help you more than sleeping pills
__________ Sleep Therapy for the Masses May Be Coming to You Soon (The New York Times): “CVS Health wants to help millions of American workers improve their sleep. So for the first time, the big pharmacy benefits manager is offering a purely digital therapy as a possible employee benefit. The company is encouraging employers to cover…
Read MoreLifestyle and neurotechnology over genetics
?” Dear colleague, It’s remarkable how quickly things are changing, finally, in brain health and mental health — see for example what’s new with Interaxon, Akili, NeuraMetrix, Apple, Calm, Halo Neuroscience, Mindstrong Health, Novartis, Pear Therapeutics, and lifelong neurogenesis, all in the last 6 months! Please enjoy the May edition of SharpBrains eNewsletter below, and consider joining the…
Read MorePear Therapeutics raises $50M to develop and market a portfolio of digital therapeutics for mental health
___ Pear Therapeutics rakes in $50M to develop additional digital therapeutics (MobiHealthNews): “Boston- and San Francisco-based Pear Therapeutics, maker of a prescription digital therapeutic platform, announced today the closure of $50 million in Series B funding. The round was led by Singapore-based investment company Temasek, with participation from returning investors 5AM Ventures, Arboretum Ventures, and…
Read MoreGood news: The Digital Revolution meets the Human Brain (as evidenced by the explosion of neurotech patent filings)
Our brain is at the core of everything we do, from the every-day decisions we make to the epic emotions we feel when we fall in love. Given its vital role in our lives, it is great news that two of the most well-funded research programs in the world focus on the brain sciences:
Read More